Share this post on:

Product Name :
Alectinib Hydrochloride

Search keywords :
Alectinib

drugId :
null

Target Vo:
Anaplastic lymphoma kinase

Target Vo Short Name :
ALK

Moa_Name:
Tyrosine-protein kinase receptor RET inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2014

Origin Company_Name :
Chugai Pharmaceutical Co Ltd

Active Company_Name :
Chugai Pharmaceutical Co Ltd

Active Indication_Name:
Lung Neoplasms

In Active Indication_Name:
Intestinal Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-STAT1 (Ser727) Antibody (YA149)
RSK1 p90 Antibody (YA088)
c-Fos Antibody: c-Fos Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to c-Fos. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related